<

Register Your Interest

What are the possible benefits of joining a clinical trial?

  • Your participation in a study helps the development of new Alzheimer’s medication
  • World-class medical care for free
  • Contribute to the advancement of scientific knowledge
  • Access new Alzheimer’s medication free of charge
  • Receive comprehensive medical monitoring and investigations for free. Your safety is our priority.
  • Join a thriving community of volunteers championing the development of Alzheimer’s research
  • Help us to raise awareness for Alzheimer’s research and dementia research
  • Learn more about our studies by clicking here

alzheimer's research

What memory studies are available for memory loss and Alzheimer’s disease?

Re:Cognition Health provides volunteers early access to disease-modifying medications for memory loss and Alzheimer’s disease. These new Alzheimer’s medications are available in international memory studies, which are being conducted across the globe.

The drugs available in the different Alzheimer’s memory studies each work in different ways. This is called the ‘mechanism of action’. As part of the initial enrolment process, our expert team will discuss all of the memory studies available at our research centres, ensuring that you are fully informed and are matched to the memory study that is most appropriate for you.

Our clinical team are very involved in the enrolment process. They are available to discuss the key requirements of the study and to educate volunteers on the different investigations and medical procedures that take place throughout the study. All of the care provided is completely free of charge.

Click here if you do not have any memory concerns 

Adult friendships

Who are we?

Re:Cognition Health is an award-winning provider of world-class medical care in the UK and USA. Our international clinics are global-leaders in providing access to new treatments for Alzheimer’s disease, free of charge. We have clinics in London, Guildford, Birmingham and Plymouth, all of which reimburse travel expenses. If you’d like to find your local clinic, simply visit our contact page 

Separate from our market-leading work in Alzheimer’s research, we specialise in a range of different conditions, using innovative diagnostic techniques to provide bespoke care to all of our patients. Areas that we specialise in include ADHD, Autism and mild Traumatic Brain Injury.

Register Your Interest

Food and depression

t

Early intervention and accurate diagnosis of the specific cause of a person’s dementia is key to ensuring the individual receives access to the correct and best treatment, at the earliest stageDr Emer MacSweeney

CEO & Medical Director

Dementia Research

Frequently Asked Questions

Q) Will I be paid?

A) Volunteers are not paid for taking part in this Alzheimer’s research. However, the sponsor will reimburse reasonable travel expenses for you and your study partner for each visit. To give you an example, for most of our current trials, the reimbursement is up to £60 for the volunteer and £60 for the study partner for each visit.

Q) How often are the visits?

A) This depends on the research study you participate in. The screening period of the study is generally when the visits are most frequent. This is when all the initial investigations are carried out to confirm whether a volunteer is eligible for a study. During the treatment stage of the study, the visits will be less frequent. Some studies require a clinic visit once a month whereas others have visits every six 6 weeks. If you do enrol onto a study, we’ll be able to give you all of your appointments in advance. 

Q) Can I leave the trial before it finishes?

A) Absolutely. Leaving a study will in no way affect your  medical or legal rights. It’s not necessary to give us a reason as to why you want to leave, although we always value any feedback from you. If you choose to leave after you have started taking the study drug, then we are obliged to offer you a final visit, to carry out final medical investigations to ensure your safety,

Q) I have vascular dementia, can I take part?

A) Unfortunately all of the current studies are for Alzheimer’s Disease. However, we are always activating new Alzheimer’s research studies so please make sure to connect with our team using the contact form so we can keep you updated.

Q) Will I get my results?

A) Yes. You will be informed of all of you results and your GP will also be made aware of any significant results. Volunteers receive comprehensive medical care in the study so you can be assured that your health will be closely monitored. These include a medical examination, blood pressure reading, urine tests, ECG, MRI head scan, a PET scan or lumbar puncture. Our team are very experienced and are always available to discuss your participation with you.

Q) Will I have to take a trial drug?

A) Yes. If you are found to be eligible for one of the clinical trials, then you can consent to be assigned to a treatment group. Depending on the trial, the trial medication can be in the form of a tablet taken orally once a day or an intravenous infusion once a month.

Q) Will I know what I am taking?

A) No. You will not know whether you are taking the active study drug or a placebo. A placebo is a dummy pill and doesn’t contain any active drug. You will be randomly assigned into one of the study groups and you and your study team will not know which group you are in. This is called a randomised, double-blind, placebo controlled trial.

Q) What if I am on placebo?

A) There is a chance that you are in the placebo group, the probability of that will depend on the trial. It may be anywhere between 1:2 to 1:3. Whichever group you are in, you will still benefit from the ongoing medical care and psychometric testing that you will receive as part of the trial. At the end of the trial period, most trials offer the opportunity for you to enter the open label extension. This is when you continue in the trial but on the active drug despite whichever group (ie. Placebo or active drug) group you were in before. The open label extension is un-blinded, so you will know you are on the active drug.

Q) Are there any side effects?

A) Any potential side effects will be listed in the patient information sheets that are sent to you prior to your initial consultation. Most of the side effects are non-specific but some trials have specific side effects that your study doctor will discuss with you. We will work closely with you and your GP to ensure your safety at all times.

Q) What is a study partner and why do I need one?

A) A study partner is someone who can accompany the participant to some study visits and answer questions about their symptoms. They should be someone who sees the volunteer regularly e.g. a spouse, relative or close friend as they will need to let us know about any potential changes in the volunteer’s health or behaviour. The number of visits they need to attend depends on each study.

Q) Do I need to tell my GP?

A) Yes and no. It is good practice to let your GP know but it is not necessary to inform your GP before your screening visit. If you are found to be eligible for the study at the screening visit, we will inform your GP and obtain a medical summary letter from your GP with your consent. We can also write to other doctors involved in your care should you wish.

Q) Where can I take part?

A) Re:Cognition Health has clinics across the UK in London, Guildford, Plymouth and Birmingham. We’ve also just opened our first clinic in the USA! You can learn more about us here

About us

Team

Contact